logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Gareth P. Gregory

monash university
H指数:27
被引数:3,225

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-Reported Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Glofitamab plus Gemcitabine and Oxaliplatin in STARGLO

在STARGLO研究中，接受Glofitamab联合吉西他滨和奥沙利铂治疗复发或难治性弥漫性大B细胞淋巴瘤患者的患者报告结局

Clinical Lymphoma Myeloma and Leukemia
IF2.7
2026-10-110
OAAI
Gareth P. Gregory; Jeremy S. Abramson; Huiqiang Huang; Qingyuan Zhang; Matthew Ku; Dok Hyun Yoon; Christopher P. Fox; Haifaa Abdulhaq; William Townsend; Joan Ashby; Alana Harris; Estefania Mulvihill; Martine Kallemeijn; Murali Kesavan; Richard Ta; Voleak Choeurng; Linda Lundberg; Huilai Zhang
Phase 1/2 study of favezelimab plus pembrolizumab in anti–PD-1–naive relapsed or refractory classical Hodgkin lymphoma

I期/II期研究：favezelimab联合pembrolizumab治疗抗PD-1初治复发或难治性经典型霍奇金淋巴瘤

Blood Advances
IF7.1
2026-10-050
OAAI
Nathalie A. Johnson; David Lavie; Peter Borchmann; Gareth P. Gregory; Alex F. Herrera; Leonard Minuk; Vladan Vucinic; Philippe Armand; Abraham Avigdor; Robin Gasiorowski; Yair Herishanu; Colm Keane; John Kuruvilla; Rachel Marceau West; Pallavi Pillai; Patricia Marinello; John M. Timmerman
End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study

治疗结束时的正电子发射断层扫描/计算机断层扫描完全缓解是结外周T细胞淋巴瘤的强预后指标：一项澳大拉西亚-加拿大合作研究

British Journal of Haematology
IF3.8
2026-08-210
PRE
Chathuri Abeyakoon; Cameron Wellard; Vanessa Murad; Eliza Chung; David Hodgson; Danielle Rodin; Anca Prica; Tomohiro Aoki; Abi Vijenthira; Umberto Falcone; Stephen Opat; Erica M. Wood; Zoe K. McQuilten; Eliza A. Hawkes; Michael Crump; John Kuruvilla; Gareth P. Gregory
Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice

复发弥漫性大B细胞淋巴瘤注册试验中纳入标准的显著差异限制了其在临床实践中的适用性

British Journal of Haematology
IF3.8
2026-05-150
OAAI
Elizabeth Goodall; Jodie Palmer; Arina Martynchyk; Niamh Waters; Fiona Swain; Tran Binh Giang; Tamara Marconi; Jamie Brennan; Gareth P. Gregory; Chan Cheah; Colm Keane; Eliza A. Hawkes
Meeting trial eligibility in Follicular lymphoma patients is associated with overall survival but not progression-free survival

滤泡性淋巴瘤患者满足临床试验入组标准与总生存期相关，但与无进展生存期无关。

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2025-09-011
PRE
Wong, Kimberly S. Q.; Martynchyk, Arina; Krisnadi, Zoe; Swain, Fiona; Zargari, Ahmad; Cassidy, Luke; Mills, Georgia; Lim, Kenneth; Gervasi, Jeremy; Smallbone, Portia; Wang, Jenny; Slifirski, Olivia; Loh, Zoe; Cheah, Chan; Keane, Colm; Gregory, Gareth; Lasica, Masa; Chong, Geoffrey; Barraclough, Allison; Cochrane, Tara; Lee, Denise; Hawkes, Eliza
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma

合理设计的嵌合PI3K-BET溴结构域抑制剂在MYC驱动的淋巴瘤中引起治疗反应

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
IF9.1
2023-08-291
OAAI
Oh, Danielle H.; Ma, Xiao; Hogg, Simon J.; He, Jackson; Kearney, Conor; Brasacchio, Daniella; Susanto, Olivia; Maher, Belinda; Jennings, Ian G.; Newbold, Andrea; Fraser, Peter; Gruber, Emily; Kats, Lev M.; Gregory, Gareth P.; Johnstone, Ricky W.; Thompson, Philip E.; Shortt, Jake
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
BLOOD ADVANCES
IF7.1
2023-08-2534
OAAI
Bartlett, Nancy L.; Assouline, Sarit; Giri, Pratyush; Schuster, Stephen J.; Cheah, Chan Y.; Matasar, Matthew; Gregory, Gareth P.; Yoon, Dok Hyun; Shadman, Mazyar; Fay, Keith; Yoon, Sung-Soo; Panizo, Carlos; Flinn, Ian; Johnston, Anna; Bosch, Francesc; Sehn, Laurie H.; Wei, Michael C.; Yin, Shen; To, Iris; Li, Chi-Chung; Huang, Huang; Kwan, Antonia; Penuel, Elicia; Budde, Lihua E.
A phase 1/2 randomized study of imvotamab monotherapy and in combination with loncastuximab tesirine in relapsed/refractory non-Hodgkin lymphomas
CANCER RESEARCH
IF16.6
2023-04-141
PRE
Diefenbach, Catherine; Kim, Won Seog; Cheah, Chan; Gopal, Ajay K.; Armand, Philippe; Flinn, Ian; Gregory, Gareth P.; Yoon, Sung-Soo; Nastoupil, Loretta; Lue, Jennifer; Ribrag, Vincent; Briones, Javier; Salar-Silvestre, Antonio; Sureda-Balari, Anna; Ku, Matthew; Cruz, Hans; Thaler, Paul; Qazi, Ibrahim; Wei, Rachel; Leabman, Maya; Hernandez, Genevive; Sison, Iris; Budde, Elizabeth
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
LEUKEMIA
IF13.4
2022-04-2214
OAAI
Wong, Jonathan; Gruber, Emily; Maher, Belinda; Waltham, Mark; Sabouri-Thompson, Zahra; Jong, Ian; Luong, Quinton; Levy, Sidney; Kumar, Beena; Brasacchio, Daniella; Jia, Wendy; So, Joan; Skinner, Hugh; Lewis, Alexander; Hogg, Simon J.; Vervoort, Stephin; DiCorleto, Carmen; Uhe, Micheleine; Gamgee, Jeanette; Opat, Stephen; Gregory, Gareth P.; Polekhina, Galina; Reynolds, John; Hawkes, Eliza A.; Kailainathan, Gajan; Gasiorowski, Robin; Kats, Lev M.; Shortt, Jake
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
BLOOD ADVANCES
IF7.1
2022-02-1618
OAAI
Gregory, Gareth P.; Kumar, Shaji; Wang, Ding; Mahadevan, Daruka; Walker, Patricia; Wagner-Johnston, Nina; Escobar, Carolina; Bannerji, Rajat; Bhutani, Divaya; Chang, Julie; Hernandez-Ilizaliturri, Francisco J.; Klein, Andreas; Pagel, John M.; Rybka, Witold; Yee, Andrew J.; Mohrbacher, Anne; Huang, Mo; Farooqui, Mohammed; Marinello, Patricia; Quach, Hang
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study

Avelumab联合治疗复发/难治性DLBCL: Ib期标枪DLBCL研究的结果

TARGETED ONCOLOGY
IF4
2021-10-2310
OAAI
Hawkes, Eliza A.; Phillips, Tycel; Budde, Lihua Elizabeth; Santoro, Armando; Saba, Nakhle S.; Roncolato, Fernando; Gregory, Gareth P.; Verhoef, Gregor; Offner, Fritz; Quero, Cristina; Radford, John; Giannopoulos, Krzysztof; Stevens, Don; Thall, Aron; Huang, Bo; Laird, A. Douglas; Sandner, Robin; Ansell, Stephen M.
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
MOLECULAR CELL
IF16.6
2021-05-0176
OAAI
Hogg, Simon J.; Motorna, Olga; Cluse, Leonie A.; Johanson, Timothy M.; Coughlan, Hannah D.; Raviram, Ramya; Myers, Robert M.; Costacurta, Matteo; Todorovski, Izabela; Pijpers, Lizzy; Bjelosevic, Stefan; Williams, Tobias; Huskins, Shannon N.; Kearney, Conor J.; Devlin, Jennifer R.; Fan, Zheng; Jabbari, Jafar S.; Martin, Ben P.; Fareh, Mohamed; Kelly, Madison J.; Dupere-Richer, Daphne; Sandow, Jarrod J.; Feran, Breon; Knight, Deborah; Khong, Tiffany; Spencer, Andrew; Harrison, Simon J.; Gregory, Gareth; Wickramasinghe, Vihandha O.; Webb, Andrew, I; Taberlay, Phillippa C.; Bromberg, Kenneth D.; Lai, Albert; Papenfuss, Anthony T.; Smyth, Gordon K.; Allan, Rhys S.; Licht, Jonathan D.; Landau, Dan A.; Abdel-Wahab, Omar; Shortt, Jake; Vervoort, Stephin J.; Johnstone, Ricky W.

研究方向

暂未获取到该数据
R
Ricky W. Johnstone
H 指数:96论文数:780被引数:3.7万
J
Jake Shortt
H 指数:35论文数:331被引数:4,536
L
Lev M. Kats
H 指数:31论文数:106被引数:1.2万
S
Stephen Opat
H 指数:40论文数:360被引数:1.0万
E
Eliza A. Hawkes
H 指数:28论文数:323被引数:3,279
S
Simon J. Hogg
H 指数:25论文数:111被引数:3,507
S
Stephin J. Vervoort
H 指数:34论文数:152被引数:4,542
I
Izabela Todorovski
H 指数:10论文数:55被引数:1,029
J
Jennifer R. Devlin
H 指数:15论文数:60被引数:1,732
M
Michael Gilbertson
H 指数:15论文数:70被引数:1,039